A Minute Gastric Cancer Detected by a New Screening Method Using Serum Pepsinogen I and II
Part of the
Advances in Experimental Medicine and Biology
book series (AEMB, volume 362)
A gastric cancer, despite a recent decline in the mortality rate, is still a leading cause of cancer death in Japan, so that considerable effort continues to be focused on the early detection of the cancer through mass screening programs throughout the country. In most workplaces, an indirect barium x-ray examination combined with endoscopic inspection has been the standard screening method used in Japan. However, this method has certain drawbacks in detecting early gastric cancers, for exsample due to the low sensitivity of the barium x-ray procedure, which is the first step of the screening process. Therefore, to improve the effectiveness of gastric cancer screening, we have established a new screening system that uses serum pepsinogen tests instead of the indirect barium x-ray method, since it has been found that the serum tests are better able to detect advanced stages of chronic atrophic gastritis  , which is thought to be a precancerous condition that lead to the development of gastric cancer. In 1991, the first gastric mass screening using this system was carried out in the workplace and here we report on the first case of minute gastric cancer detected by this new screening method.
KeywordsGastric Cancer Early Gastric Cancer Chronic Atrophic Gastritis Gastric Cancer Case Serum Pepsinogen
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
K. Miki, M. Ichinose, A. Shimizu, et al., Serum pepsinogens as a screening test of extensive chronic gastritis, Gsatroenterol. Jpn.
22:133 (1987)Google Scholar
K. Miki, M. Ichimose, N. Kawamura, et al., The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects, Jpn. J. Cancer Res.
80:111 (1989)PubMedCrossRefGoogle Scholar
K. Miki, M. Ichimose, K.B. Ishikawa, et al., Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer, Jpn. J. Cancer Res.
84:1086 (1993)PubMedCrossRefGoogle Scholar
I. Kushner, W. Rapp, P. Brutin, et al.
Electrophoretic and immunochemical demonstration of the existence of four human pepsinogens, J. Clin. Invest.
43:1983 (1964)PubMedCrossRefGoogle Scholar
I.M. Samloff, Pepsinogens, pepsins and pepsin inhibitors, Gastroenterology
60:586 (1971)PubMedGoogle Scholar
B.I. Hirschowitz, Pepsinogen; its origin, secretion and excretion, Physiol. Rev.
37:475 (1957)PubMedGoogle Scholar
O.A.A. Bock, G. Arapakis, L.J. Witts and C.D. Richards, The serum pepsinogen level with special reference to the histology of the stomach mucosa, Gut
4:106 (1963)PubMedCrossRefGoogle Scholar
I.M. Samloff, K. Varis, T. Ihamaki, M. Siurala and J.I. Rotter, Relationship among serum pepsiongen I, serum pepsinogen II and gastric mucosal histology, Gastroenterology
83:204 (1982)PubMedGoogle Scholar
P. Correa, The gastric precancerous process, Cancer Surveys
2:437 (1983)Google Scholar
T. Imai, T. Kubo and H. Watanabe, Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma, J. Natl. Cancer Inst.
47:179 (1971)PubMedGoogle Scholar
R. Cheli, L. Simon, H. Aste, et al., Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations, Endoscopy
12:105 (1980)PubMedCrossRefGoogle Scholar
M. Ichinose, K. Miki, C. Furihata, et al., Radioimmunoassay of group II pepsinogens in human serum, Clin. Chim. Acta
122:61 (1982)PubMedCrossRefGoogle Scholar
M. Ichinose, K. Miki, C. Furihata, et al., Radioimmunoassay of group I and group II pepsinogens in normal controls and patients with various disorders, Clin. Chim. Acta
126:183 (1982)PubMedCrossRefGoogle Scholar
© Springer Science+Business Media New York 1995